Search Results 91-100 of 1292 for ❤정품 레비트라 구매대행 {정력원.COM} 칵스타 온라인 구매❤

  1. ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension - Mayo Clinic

    About this study. The purpsoe of this study is to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to ...

  2. Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS - Mayo Clinic

    About this study. This 2-stage, open-label study will evaluate safety and pharmacokinetics of ASTX727, as well as determine the dose for the study's second ...

  3. Obstetrics and Gynecology - Clinical trials

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Help Fund Research.

  4. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with ...

  5. ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency - Mayo Clinic

    The purpose of this study (Study INZ701-304 [ADAPT])) is to assess the long-term safety of INZ-701 in patients with ENPP1 Deficiency or ABCC6 Deficiency who ...

  6. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  7. Study of LY2784544 Testing Alternative Dosing in Participants with Myeloproliferative Neoplasms - Mayo Clinic

    The purpose of this study is to determine a dose of LY2784544 that may be safely administered to participants with myeloproliferative neoplasms. Participation ...

  8. Study of RP-6306 Alone or in Combination With RP-3500 in Patients With Advanced Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility.

  10. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

    Approximately 358 patients will be randomized in a 1:1 ratio to DCC-2618 150 mg once daily (QD) (continuous dosing for 6 week cycles) or sunitinib 50 mg QD (6 ...